F. Bieri
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
- Lipid metabolism and biosynthesis
Papers in
- Pharmacology 14
- Drug-Induced Hepatotoxicity and Protection 8
- Pharmacogenetics and Drug Metabolism 7
-
- Carcinogens and Genotoxicity Assessment 14
- Co-authors
- W. Stäubli (28 shared papers)Philip Bentley (27 shared papers)Felix Waechter (11 shared papers)Samar F. Muakkassah-Kelly (13 shared papers)F. Waechter (18 shared papers)Étienne-Émile Baulieu (1 shared paper)H. Dariush Fahimi (1 shared paper)Miguel Bronfman (1 shared paper)
- Journals
- Carcinogenesis (4 papers)Biochemical Pharmacology (3 papers)Toxicology in Vitro (3 papers)Food and Chemical Toxicology (2 papers)Toxicology Letters (2 papers)
- Partner nations
- SwitzerlandFranceGermany
In The Last Decade
F. Bieri
31 papers receiving 573 citations
Peers
Comparison fields: 5 of 53
- Pharmacology 170
- Biochemistry 86
- Cancer Research 158
- Hepatology 101
- Molecular Biology 292
Countries citing papers authored by F. Bieri
This map shows the geographic impact of F. Bieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Bieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Bieri more than expected).
Fields of papers citing papers by F. Bieri
This network shows the impact of papers produced by F. Bieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Bieri. The network helps show where F. Bieri may publish in the future.
Co-authors
The 21 scholars most cited alongside F. Bieri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1984 | 83 | |
| 2 | 1989 | 65 | |
| 3 | 1987 | 62 | |
| 4 | 1983 | 54 | |
| 5 | 1984 | 53 | |
| 6 | 1990 | 53 | |
| 7 | 1971 | 33 | |
| 8 | 1984 | 28 | |
| 9 | 1989 | 28 | |
| 10 | 1988 | 22 | |
| 11 | 1988 | 21 | |
| 12 | 1988 | 20 | |
| 13 | 1988 | 15 | |
| 14 | 1988 | 12 | |
| 15 | 1988 | 12 | |
| 16 | 1990 | 12 | |
| 17 | 1993 | 12 | |
| 18 | 1987 | 10 | |
| 19 | 1990 | 9 | |
| 20 | 1991 | 9 |
About F. Bieri
F. Bieri is a scholar working on Pharmacology, Cancer Research, Hepatology, Molecular Biology and Biochemistry, having authored 32 papers that have together received 674 indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (17 papers), Carcinogens and Genotoxicity Assessment (14 papers), Drug-Induced Hepatotoxicity and Protection (8 papers), Pharmacogenetics and Drug Metabolism (7 papers), Liver physiology and pathology (6 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Nuclear Structure and Function (1 paper) and Estrogen and related hormone effects (1 paper). The work is most often cited by research in Pharmacology (170 citations), Biochemistry (86 citations), Cancer Research (158 citations), Hepatology (101 citations) and Molecular Biology (292 citations). F. Bieri has collaborated with scholars based in Switzerland, France and Germany. Frequent co-authors include W. Stäubli, Philip Bentley, Felix Waechter, Samar F. Muakkassah-Kelly, F. Waechter, Étienne-Émile Baulieu, H. Dariush Fahimi, Miguel Bronfman, Alfred Völkl and Ariel Orellana. Their work appears in journals such as Carcinogenesis, Biochemical Pharmacology, Toxicology in Vitro, Food and Chemical Toxicology and Toxicology Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.